Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
New York, USA, May 13, 2025 (GLOBE NEWSWIRE) -- Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight ...
-
New York, USA, May 12, 2025 (GLOBE NEWSWIRE) -- Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight The blood cancer market...
-
New York, USA, May 08, 2025 (GLOBE NEWSWIRE) -- Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight The growing prevalence of chronic and infectious diseases is a...
-
New York, USA, May 08, 2025 (GLOBE NEWSWIRE) -- High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight As per...
-
New York, USA, May 07, 2025 (GLOBE NEWSWIRE) -- Global AI in Clinical Trials Market to Show Tremendous Growth at a CAGR of ~12% by 2032 | DelveInsight The demand for AI in clinical trials is...
-
New York, USA, May 06, 2025 (GLOBE NEWSWIRE) -- Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses...
-
New York, USA, May 05, 2025 (GLOBE NEWSWIRE) -- Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight The prostate...
-
New York, USA, May 01, 2025 (GLOBE NEWSWIRE) -- Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight The molecular...
-
New York, USA, May 01, 2025 (GLOBE NEWSWIRE) -- Schizophrenia Market to Witness Significant Growth by 2034 Across 7MM as New Therapies Enter Late-Stage Trials | DelveInsight The schizophrenia...
-
New York, USA, April 30, 2025 (GLOBE NEWSWIRE) -- Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight In recent years, the...